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Abstr act
It is generally recognized that the major obstacle to efficient gene delivery is cellular internalization and endosomal escape of the DNA. Recently, we have developed a modular strategy for the preparation of well-defined polycationic amphiphilic cyclodextrins (paCDs) capable of complexing and compacting DNA into homogeneous nanoparticles (<70 nm).
Since paCDs resemble both cationic polymers and cationic lipids, it is conceivable that the corresponding pDNA-paCD nanoparticles (CDplexes) might use the cell uptake and endosomal escape mechanisms described for both lipoplexes and polyplexes. To verify this hypothesis, we have now investigated the uptake and transfection efficiencies of CDplexes in the presence of several inhibitors of endocytosis, namely chlorpromazine, genistein, dynasore and methylated β-cyclodextrin (MbCD). Our data show that CDplexes obtained from paCD 1, which ranks among the most efficient paCD gene vectors reported up to date, are internalized by both clathrin-dependent (CDE) and clathrin-independent endocytosis (CIE), both processes being cholesterol-and dynamin-dependent. We observed that the largest fraction of gene complexes is taken up via CDE, but this fraction is less relevant for transfection. The smaller fraction that is internalized via the CIE pathway is predominantly responsible for successful transfection.
Intr oduction
The successful delivery of therapeutic genes into cells and their availability at the intracellular site of action are crucial requirements for successful gene therapy. During the last decade, under the advent of nanotechnology, a broad diversity of creative materials featuring promising properties for nonviral gene delivery applications has emerged, (1) . Cationic polymers and lipids, or their combinations, have shown the ability to bind nucleic acids through electrostatic interactions and condense them into complexes that can be readily internalized by cells (2) (3) . The gene delivering capabilities of many of these systems have been thoroughly investigated. Yet, drawing firm conclusions that might serve to provide feedback for the design of improved delivery entities is a delicate issue as a consequence of the essentially polydisperse nature of such structures (4) .
The control of the architecture of multifunctional macromolecules is a major determinant in the rational design of successful nonviral gene delivery systems. Novel strategies have been implemented to build up well defined constructs featuring selfassembling capabilities in the presence of nucleic acids. In this context, the unique characteristics of dendrimers and other highly ordered clusters, such as uniformity, monodispersity and multivalency, have attracted increasing attention (5) (6) (7) (8) . Homogeneous external functionalization of these platforms becomes, however, exponentially more complicated as the dendrimer generation increases (9) (10) . The use of preorganized macrocyclic scaffolds, such as calixarenes, to achieve a precise alignment of functional elements represents an interesting alternative (11) (12) (13) (14) . The commercially available cyclomaltooligosaccharides (cyclodextrins; CDs) appear particularly attractive on those grounds (15) (16) . CDs combine biocompatibility, availability, and a tubular symmetric framework with well differentiated faces that can be selectively modified in order to attain an exquisite control of the presentation and orientation of the assembled elements (17) (18) (19) .
Chemically modified CDs have been already incorporated into polycationic polymers that can effectively complex and deliver plasmid DNA (pDNA) (20) (21) . More recently, monodisperse polycationic CD conjugates with promising pDNA delivery capabilities were prepared by homogeneous functionalization of the CD primary rim (22) (23) (24) . Aiming at merging the virtues of both cationic polymers and cationic lipids in a flexible, well defined framework, we have reported a modular synthetic strategy for the preparation of polycationic amphiphilic CDs (paCDs) that allows the installation of different building blocks onto either face of the truncated-cone structure in a sequential and controlled way, offering a unique opportunity for structure-activity relationship (SAR) studies (25) (26) (27) (Figure 1 ). The pDNA complexing capabilities and in vitro transfection efficiencies of the corresponding pDNA-paCDs complexes (CDplexes) were found to be dependent on the CD decoration pattern. Notably, transfection efficiencies surpassing that of commercial polyethyleneimine (PEI) polymersbased polyplexes for BNL-CL2 and COS-7 cell lines were observed for some paCD representatives, such as 1 (28) (Figure 2 ). Since paCDs resemble both cationic polymers and cationic lipids, it is conceivable that the resulting pDNA-paCD nanoparticles (CDplexes) might be taken up by the cells and later released from the endosomes by mechanisms earlier described for both lipo-and polyplexes.
In eukaryotic cells the following mechanisms of endocytosis can be distinguished: phagocytosis, macropinocytosis (MP), clathrin dependent endocytosis (CDE) and clathrin independent endocytosis (CIE) (29) . Phagocytosis is typically restricted to specialized cells such as macrophages, whereas macropinocytosis is a constitutive bulk internalization process typically characterized by the formation of membrane protrusions and engulfing large volumes (30) . CDE and CIE are the most relevant mechanisms operating in the internalization of pDNA-nonviral gene delivery system complexes. The first route is characterized by the formation of clathrin coated pits (31) . CIE includes several pathways which share a cholesterol dependency (32) , among which caveolin mediated endocytosis Cav-ME is probably the most thoroughly characterized. In this case the membrane of the formed vesicles, which are called cavicles, typically contains caveolin-1 (33, 34) . Selective inhibition of the different internalization pathways has been shown to be a powerful tool to investigate uptake mechanisms of nanoparticles and infer the relevance of the blocked pathway in the internalization mechanism (32, (35) (36) (37) (38) (39) (40) (41) (42) (43) . Previous studies have shown that lipoplexes enter the cells predominantly via CDE (44) . Polyplexes, however, are internalized less uniformly. Their uptake seems to occur via MP and CDE as well as CIE (44) . Nonetheless, it has been observed for PEI complexes that it is predominantly the fraction that is taken up via CIE that leads to gene expression (45) (46) (47) .
The purpose of this work was to get insight on the uptake mechanisms of pDNA-paCD nanoparticles and study whether the different internalization pathways might influence the intracellular fate of the CDplexes and their transfection efficiency. The dendritic tetradecacationic paCD 1, for which a gram-scale synthetic procedure has been optimized, was selected for this study since it was previously shown to form small (< 70 nm) CDplexes in which pDNA was fully protected from degradation, with transfection efficiencies up to one order of magnitude higher as compared to branched PEI (25 KDa) in BNL-CL2 and COS-7 cells both in serum free and serum-containing (10%) media (28) . A set of selective endocytic pathway inhibitors, including chlorpromazine, genistein, dynasore and methylated β-cyclodextrin (MbCD), have been used in the present study. In addition, a fluorescently labeled (lissamine-rhodamine) derivative of paCD 1 has been synthesized to study uptake and intracellular trafficking of the CDplexes by confocal laser scanning microscopy.
Exper imental Section

General Methods
Reagents and solvents were purchased from commercial sources and used without further purification, except for dichloromethane, which was distilled over CaH 2 mmol) in dry dioxane (15 mL), triphenylphosphine (0.55 g, 1.1 eq, 2.1 mmol) and carbon disulfide (1.14 mL, 10 eq, 18.9 mmol) were added. The reaction mixture was stirred under N 2
atmosphere for 16 h. Then the solvent was removed under reduced pressure and the residue was purified by column chromatography using 1:2 EtOAc-petroleum ether as eluent to give 8 (0.63 g, 86 %) having physicochemical properties identical to those previously reported (28) . Plasmid Preparation and Labeling.
For transfection, the luciferase encoding plasmid pGL4.13 (Promega, Leiden, The Netherlands) was used. The plasmid was transformed into the competent E. coli DH10b strain value (average of three independent experiments). The 0% uptake was determined from cells incubated at 4 °C. The 100% uptake was determined from cells that had been incubated with the complexes without being exposed to any inhibitor.
Inhibitor Studies
Prior to incubation with CDplexes, Vero cells were pre-incubated with chlorpromazine, MbCD, genistein or dynasore prepared in OptiMEM (1 h, 37 °C).
Subsequently this medium was removed and substitute with OptiMEM containing fresh inhibitor and complexes. The following stock solutions of inhibitors were used: freshly prepared 10 mg mL -1 chlorpromazine in water, freshly prepared 5 mM (6.6 mg mL Above this concentration, larger aggregates might be formed and self-quench fluorescence might occur.
Uptake Kinetics of CDplexes
We have previously reported that paCD 1 efficiently complexes plasmid DNA (pDNA) forming positively charged particles (65 nm mean hydrodynamic diameter, ζ-potential +40 mV at N/P 10) (28) . Transfection experiments with the newly prepared 1:pDNA (pCMV-Luc) on HeLa cells indicated that maximum transfection efficiency occurred at N/P 5 ( Figure 3) . Interestingly, transfection mediated by these CDplexes was only slightly affected by the presence of serum, known to be a major limitation for efficient application of cationic carriers ( Figure 3A ). As expected, expression of the luciferase gene decreased over the time, though enzyme activity was still detectable at day 10 when the experiment was concluded ( Figure 3B ).
The uptake kinetics of the CDplexes by Vero cells, using YOYO-1 labeled DNA, is presented in Figure 4 . After 1 h-incubation the CDplexes were taken up by the entire population of the cells. The mean fluorescence, shown in the white bars, gradually increased till it reached a plateau after 3 h. Longer incubation times did not result in further increase of cell associated fluorescence. These data indicate that 2-h-incubation should be sufficient for efficient uptake of CDplexes by cells.
Uptake of CDplexes was also monitored by confocal microscopy using the fluorescently labeled paCD 10. Snapshots at different time points are presented in Figure 5 .
Fluorescently-labeled CDplexes were internalized already 40 min after adding them to the cells ( Figure 5A ). The amount of intracellular CDplexes increased over the time, as shown in
Figures 5B and C, and tended to accumulated in the vicinity of the nucleus. The complexes could be still detected intracellularly after 48 h ( Figure 5D ).
In some micrographs, large CDplex particles are visible outside the cell ( Figure 5A ), indicating that either paCD-pDNA complexes or paCD particles alone can aggregate in the extracellular milieu. Another interesting feature is the absence of accumulation of CDplexes or paCDs at the cellular membrane, ruling out the possibility of irreversible hydrophobic interactions between membrane lipids and the hydrocarbon tails of CDs. It is conceivable that in order to shield from the polar environment, hydrocarbon chains are oriented towards the inner core of the CDplex, which limits their interaction with plasma membrane lipids.
Endocytosis of CDplexes in the Presence of Inhibitors
To gain inside into the relative contribution of the different endocytotic pathways in CDplex-mediated transfection, four endocytosis inhibitors were applied: (i) genistein, a tyrosine-kinase inhibitor that causes local disruption of the actin network at the site of endocytosis and inhibits the recruitment of dynamin II, both known to be indispensable events in the caveolae-mediated uptake mechanism (50,51); (ii) dynasore, an inhibitor that blocks dynamin activity, disturbing the pinching off of newly formed vesicles, a process that is known to be essential for at least CDE (52); (iii) chlorpromazine, a cationic amphiphilic drug which is believed to inhibit clathrin-coated pit formation by a reversible translocation of clathrin and its adapter proteins from the plasma membrane to intracellular vesicles (53) , and (iv) methyl β-cyclodextrin (MbCD), a randomly methylated cyclomaltoheptaose derivative that inhibits cholesterol-dependent endocytic processes by reversibly extracting the steroid out of the plasma membrane (54).
To establish an optimal protocol for the use of the inhibitors, cell viability in their presence was first determined. Different concentrations of each inhibitor were tested in the absence and in the presence of CDplexes prepared at two different N/P ratios (5 and 10).
Cellular toxicity was assessed with the CellTiterGlo cell viability test. The results are shown in Figure 6 .
Genistein alone showed limited toxicity towards Vero cells after 5 h incubation. The highest concentration tested (400 mM) reduced viability by less than 20% ( Figure 6A ).
Incubation in the presence of genistein and CDplexes turned out to increase toxicity, especially at the higher N/P ratio (26% and 75% viability decrease for N/P 5 and 10, respectively). Dynasore (20-50 µM) displayed only moderate toxicity on Vero cells ( Figure   6B ). At the highest concentration (50 µM), viability was lowered by 20% only. In combination with CDplexes, cell viability decreased by around 10% and 40% for N/P 5 and 10, respectively. Remarkably, increasing dynasore concentrations apparently protected Vero cells from paCDs-induced toxicity, possibly due to an efficient endocytosis blocking effect (see below). Vero cells were virtually insensitive to chlorpromazine up to 10 µg mL -1 for 5 h.
Higher concentrations, on the other hand, led to 100% cell death ( Figure 6C ). Chlorpromazine at 10 mg mL -1 , in combination with CDplexes (N/P 10), reduced cell viability by as much as 70%. Treatment with MbCD caused cytotoxicity at concentrations higher than 7.5 mM ( Figure   6D ), while combined incubation with MbCD (5 mM) and CDplexes (N/P 10) resulted in 50% cell viability.
Inhibitor concentrations for further transfection experiments were selected based on the toxicity assays described above. Thus, Vero cells were preincubated for 1 h with 400 µM genistein, 50 µM dynasore, 10 µg mL -1 chlorpromazine or with 5 mM MbCD. Next, the cells were incubated for 2 h with the YOYO-1 labeled CDplexes in the presence of the corresponding inhibitor. Figure 7 shows that after treatment with genistein, chlorpromazine and MbCD, CDplexes still were internalized by almost all the cells, albeit in lower amount.
MbCD and chlorpromazine reduced the average cellular uptake of gene complexes by 80%, while genistein lowered the cellular uptake of the CDplexes only by 50%. In contrast, the uptake of the CDplexes was almost completely inhibited by dynasore. This would indicate that the uptake of CDplexes by Vero cells is strongly dependent on dynamin activity, but a large fraction of uptake is also dependent on the presence of cholesterol in the plasma membrane and the availability of clathrin at the cytoplasmic side of the plasma membrane.
Furthermore, considering the efficient inhibition of CDplex uptake in the presence of chlorpromazine, known to block clathrin coated pit formation (53), we can conclude that CDE probably is a major route for CDplex internalization in Vero cells. However, the fact that genistein, known to interfere with internalization via caveolae (50), partially inhibited CDplex uptake does not rule out CIE routes, even if the fraction of the complexes that enter Vero cells via CDE seems to be larger than the fraction that enters via CIE.
In addition to the effect of inhibitors on the uptake of complexes we measured their effect on transfection efficiency by assaying luciferase activity 48 h after transfection ( Figure   8 ). Genistein appeared to completely inhibit luciferase expression at 400 µM. Also dynasore inhibited transfection very efficiently at 50 µM. In the case of chlorpromazine, transfection efficiency was reduced by 50% at 10 µg mL -1 . No luciferase activity was measured at higher chlorpromazine concentrations, although this is probably due to the cytotoxic combination of 14 chlorpromazine (> 10 µg mL -1 ) and CDplexes that resulted in almost 100% cell death (see above). In case of MbCD, concentrations of 5 mM or higher resulted in more than 80% decrease of reporter gene expression.
Conclusions
Our results demonstrate that CDplex-mediated transfection is a complex process simultaneously involving several cellular uptake mechanisms. Chlorpromazine, an inhibitor of CDE, although decreasing internalization by 76%, only partially inhibited transfection. This indicates that the small fraction that is internalized via CIE (24%) is still able to bring about moderate transfection, thus reducing the relevance of CDE route for CDplex-mediated transfection. This result is supported by the fact that genistein, an inhibitor of CIE, although reducing CDplex uptake by 50% only, completely abolished luciferase expression, pointing to the inefficiency of clathrin-coated endosomes to deliver the pDNA functionally to its target.
Possibly, in this case the cargo cannot escape from the endosomes and is ultimately degraded in lysosomal compartments. These findings are in agreement with former studies on the internalization of polyplexes (45) (46) (47) . It must be emphasized, however, that the present observations and conclusions cannot be generalized or extrapolated to other types of DNApaCD complexes or even other cell lines. The whole process of uptake, processing and gene expression is strongly dependent on the carrier as well as cell type and therefore should be specifically studied in a case-to-case manner. 
